Nav: Home

The promise and peril of emerging reproductive technologies

January 11, 2017

In vitro fertilization has transformed reproductive medicine and sparked a number of therapeutic and diagnostic breakthroughs.

Now a new, still experimental, technique known as in vitro gametogenesis (IVG) is poised to usher in the next era in reproductive and regenerative medicine. The approach--thus far successful only in mice--allows scientists to create embryos in a lab by reprogramming any type of adult cell to become a sperm or egg cell.

In a newly published commentary, a trio of scholars argue that while IVG carries a promise to unravel the fundamental mechanisms of devastating genetic forms of infertility and to pave the way to a range of new therapies, the technique also raises a number of vexing legal and ethical questions that society should address before IVG becomes ready for prime-time clinical use in human patients.

The article, published Jan. 11 in Science Translational Medicine, is authored by I. Glenn Cohen, professor at Harvard Law School, George Q. Daley, dean of Harvard Medical School, and Eli Y. Adashi, professor of medical science and former dean of medicine and biological sciences at Brown University.

IVG holds enormous potential not only as a treatment for infertility, but also for a constellation of currently untreatable diseases, the authors write. Additionally, they note, the technique may provide an inexhaustible supply of lab-made embryonic stem cells for research and therapeutic use as a tantalizing alternative to scarce human embryonic stem cells, which are currently in limited supply due to ethical considerations and regulatory restrictions.

Yet, the authors say, such promises come with some worrisome scientific, legal and ethical challenges, such as the need for rigorous scientific protocols to ensure that any reproductive cells created through IVG are free of genetic aberrations, the threat of improper commercialization of IVG for large-scale embryonic generation and the use of preimplantation genetic screening to create "designer" offspring.

The authors acknowledge that clinical uses of IVG in the foreseeable future remain improbable at best. The impact of IVG, they say, will likely be limited to enhancing the science of germ cell biology. Yet, they caution, some clinical uses may arrive much sooner than anticipated, given the breakneck speed at which science and medicine are advancing.

To prepare for that time, scientists, bioethicists, policymakers, legal scholars and the public should initiate and maintain a vigorous conversation about the implications of IVG.

"Emerging technologies carry enormous promise but can also be profoundly disruptive. Aligning their promise with ethical and legal considerations is an imperative not only for scientists but for the society as a whole," said George Q. Daley, dean of Harvard Medical School. "To do so, we must initiate vital conversations early and engage the public. Nothing less will do on our quest to ensure that we strike the right balance between our most audacious scientific pursuits and our core ethical and legal principles."

The authors go on to say that the United States might be wise to borrow a page from the U.K.'s playbook, where a protocol focused on safety, ethics and public consultation has recently led to the launch of government-sponsored clinical studies of mitochondrial replacement therapy, a lab-based procedure that replaces defective mitochondrial DNA in a woman's egg cells with healthy DNA to avert passing the defects to her offspring.

"IVG has the potential to upend one of the most traditional elements of human culture--our understanding of what parenthood is and how it occurs," says Cohen, who is also the faculty director of thePetrie-Flom Center for Health Law Policy, Biotechnology and Bioethics at Harvard. "It is critical for law and medical ethics to grapple with the far-ranging implications of this new technology."

Scientific and therapeutic promise of IVG

  • IVG could help scientists unravel the cellular and molecular aberrations responsible for DNA defects that cause a range of inherited diseases.

  • The technology may be used as a fertility-salvaging strategy in prepubertal children who undergo cancer treatments that damage their immature reproductive organs and tissues.

  • Certain inherited forms of infertility may become treatable by implanting healthy, genetically edited reproductive cells.

  • The approach could prevent devastating mitochondrial diseases by creating egg cells, or oocytes, free of mitochondrial DNA defects.

  • IVG may offer a safer alternative to traditional IVF treatments that require ovarian stimulation with injectable hormones, a procedure that carries a small but serious risk of harm.

Ethical perils, scientific challenges and legal considerations

  • Current reprogramming technology used to coax adult cells into becoming multipurpose cells has advanced by leaps and bounds, but it may be far from foolproof, the authors argue. Therefore, perfecting existing techniques before any clinical use is critical to ensuring that both the original adult cells and the multipurpose cells they give rise to are free of genetic and epigenetic aberrations.

  • Refining the science of IVG will, at least initially, require the generation and possible destruction of lab-made human embryos derived from stem cells. Under current U.S. law, such scientific pursuits would not be eligible for federal funding.

  • IVG has the potential to rapidly and cheaply generate multiple embryos, which could reignite age-old concerns about "embryo farming" and commodification of human reproduction. How should regulators deal with that reality? Is the current federal and state scrutiny of sperm and egg banks an appropriate model?

  • Widespread clinical use of IVG may also spark worries about human enhancement via preimplantation genetic diagnoses. The practice is already used with traditional in vitro fertilization to screen embryos for serious genetic defects. However, with a potentially unlimited supply of IVG-generated embryos, there may be concerns that some parents could select embryos for offspring based on preferred genetic traits unrelated to disease and health.

  • Another potential concern is the prospect that IVG could enable direct gene modification via gene editing, which is now more feasible with emerging technologies like CRISPR. Hence, gene editing of germ cells could be practiced for genetic enhancement, raising considerable ethical concerns.

  • IVG also increases the risk for unauthorized--or even surreptitious--use of biological material such as hair or skin cells to generate human embryos. That possibility is not only ethically troubling but also raises worrisome legal questions cutting to the very core of the legal definition of parenthood.

-end-
Harvard Medical School

Harvard Medical School has more than 9,500 full-time faculty working in 10 academic departments located at the School's Boston campus or in hospital-based clinical departments at 15 Harvard-affiliated teaching hospitals and research institutes: Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Cambridge Health Alliance, Dana-Farber Cancer Institute, Harvard Pilgrim Health Care Institute, Hebrew SeniorLife, Joslin Diabetes Center, Judge Baker Children's Center, Massachusetts Eye and Ear/Schepens Eye Research Institute, Massachusetts General Hospital, McLean Hospital, Mount Auburn Hospital, Spaulding Rehabilitation Network and VA Boston Healthcare System.

The Harvard Medical School Center for Bioethics

The Harvard Medical School Center for Bioethics was launched to ensure that values and ethics are always part of medical training, laboratory and clinical research, and professional education. The Center's mission is to bring together the rich intellectual resources of the medical school faculty with health professionals and scientists from our affiliated teaching hospitals, departments across Harvard, and colleagues from other institutions worldwide to ensure that scientific progress, medical therapeutics and health care practices proceed hand-in-hand with reflection about the profound moral questions raised by advances in the life sciences.

The Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics at Harvard Law School

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School was founded in 2005 through a generous gift from Joseph H. Flom and the Carroll and Milton Petrie Foundation. The Center's founding mission was to promote interdisciplinary analysis and legal scholarship in these fields. Today, the Center has grown into a leading research program dedicated to the unbiased legal and ethical analysis of pressing questions facing health policymakers, medical professionals, patients, families, and others who influence and are influenced by health care and the health care system. To achieve this goal, the Center fosters a community of leading intellectuals, practitioners, and policymakers from a variety of backgrounds at all stages in their careers, across Harvard University and across the world.

Harvard Medical School

Related Stem Cells Articles:

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.
First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.
Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.
The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.
Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.
New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.
NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.
Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.
In mice, stem cells seem to work in fighting obesity! What about stem cells in humans?
This release aims to summarize the available literature in regard to the effect of Mesenchymal Stem Cells transplantation on obesity and related comorbidities from the animal model.
TSRI researchers identify gene responsible for mesenchymal stem cells' stem-ness'
Researchers at The Scripps Research Institute recently published a study in the journal Cell Death and Differentiation identifying factors crucial to mesenchymal stem cell differentiation, providing insight into how these cells should be studied for clinical purposes.
More Stem Cells News and Stem Cells Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Uncharted
There's so much we've yet to explore–from outer space to the deep ocean to our own brains. This hour, Manoush goes on a journey through those uncharted places, led by TED Science Curator David Biello.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 2: Every Day is Ignaz Semmelweis Day
It began with a tweet: "EVERY DAY IS IGNAZ SEMMELWEIS DAY." Carl Zimmer – tweet author, acclaimed science writer and friend of the show – tells the story of a mysterious, deadly illness that struck 19th century Vienna, and the ill-fated hero who uncovered its cure ... and gave us our best weapon (so far) against the current global pandemic. This episode was reported and produced with help from Bethel Habte and Latif Nasser. Support Radiolab today at Radiolab.org/donate.